How Should Miaite (Pronidesivir) Be Used
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, is a groundbreaking antiviral medication developed specifically for treating Feline Infectious Peritonitis (FIP). Approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, NeoFipronis is the world's first officially registered oral treatment for FIP, offering a safe, non-invasive, and highly effective therapy option for affected cats.
FIP is a fatal disease caused by certain strains of feline coronavirus, leading to symptoms such as loss of appetite, lethargy, fever, fluid accumulation in the abdomen and chest, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. NeoFipronis has demonstrated remarkable success in alleviating these symptoms, significantly improving the prognosis of infected cats. Its rapid absorption and onset of action, combined with minimal side effects, make it a preferred choice among veterinarians and pet owners seeking effective FIP treatment.
Usage Guidelines
The recommended dosage of NeoFipronis depends on the cat's weight. Administer 15 mg per kilogram of body weight once daily, which equates to half a tablet for typical dosing. For neurological or ocular forms of FIP, dosage may be increased to 30 mg/kg, but this should always be done under veterinary supervision. It is crucial to follow the prescribed dosage strictly to ensure complete viral suppression and reduce the risk of drug resistance.
Administer NeoFipronis on an empty stomach—either one hour before meals or two hours after—to optimize absorption. Consistency in administration is essential; treatment should continue uninterrupted for no less than 12 weeks. Do not skip doses, as inconsistent medication can compromise efficacy and lead to relapse or resistance.
Monitoring and Precautions
During treatment, closely observe your cat’s appetite, body temperature, activity levels, and overall health. Regular veterinary check-ups are vital, including blood tests and assessments of liver and kidney functions, to monitor for any adverse effects and ensure the medication’s safety. NeoFipronis is generally well tolerated, with few reported side effects, but any unusual symptoms should prompt immediate veterinary consultation.
While NeoFipronis is classified as an over-the-counter medication, it is highly recommended to use it under the guidance of a veterinarian experienced in FIP management. Proper veterinary oversight ensures correct dosing, monitors treatment response, and manages any complications that may arise.
Safety and Legal Information
NeoFipronis is exclusively for use in cats and should never be administered to humans or other animals. Purchase exclusively through authorized sources or the official NeoFipronis website to guarantee product quality and authenticity. Misuse or unregulated purchase may lead to ineffective treatment or adverse reactions.
Summary
NeoFipronis (Pronidesivir) offers a promising therapeutic option for cats diagnosed with FIP, transforming an otherwise terminal disease into a manageable condition. Used correctly, under veterinary supervision, it can greatly enhance survival rates, improve quality of life, and reduce symptoms associated with FIP. Adhering to prescribed dosages, complete treatment duration, and regular monitoring are essential to achieve the best outcomes with this innovative antiviral therapy.
